ChemoMetec holds annual general meeting
Bitget2026/10/08 17:57ChemoMetec held its annual general meeting on Oct. 8, 2026. Shareholders adopted the 2025/26 annual report, endorsed the board’s review of the year, and granted discharge to directors and executives. Profit appropriation was adopted, including a resolution to pay no dividend for 2025/26. Shareholders backed keeping the board at five members, then confirmed the existing directors for another term. PwC was appointed auditor, while authorization to buy back the company’s own shares was also adopted. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ChemoMetec A/S published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610081357OMX_____CNEWS_EN_GNW1001277045_en) on October 08, 2026, and is solely responsible for the information contained therein.
- ChemoMetec held its annual general meeting on Oct. 8, 2026.
- Shareholders adopted the 2025/26 annual report, endorsed the board’s review of the year, and granted discharge to directors and executives.
- Profit appropriation was adopted, including a resolution to pay no dividend for 2025/26.
- Shareholders backed keeping the board at five members, then confirmed the existing directors for another term.
- PwC was appointed auditor, while authorization to buy back the company’s own shares was also adopted.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq
Canadian used car dealer UC Automotive has applied for a Nasdaq IPO, aiming to raise up to $29 million, with its main focus on the Greater Vancouver market. Kingswood is the sole underwriter.
Swiss Franc weakens as Fed hawkish outlook lifts USD/CHF
Crypto prices
More
